Q1 EPS Forecast for Dianthus Therapeutics Lifted by Analyst
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Analysts at HC Wainwright boosted their Q1 2025 EPS estimates for shares of Dianthus Therapeutics in a research report issued on Wednesday, March 12th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($1.03) per share for the quarter, up from their prior estimate […]
